Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB00430ApprovedSmall molecule
Cefpiramide is a third-generation cephalosporin antibiotic.
- Mechanism
- Curator reviewed
The bactericidal activity of cefpiramide results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
- Primary indication
- For treatment of severe infections caused by susceptible bacteria such as P. aeruginosa.Curator reviewed
- Formula / weight
- C25H24N8O7S2 · 612.637 g/mol (avg)
- Code names
- SM-1652
Resolves to
Clinical / RWD
Structure
InChIKey
PWAUCHMQEXVFJR-PMAPCBKXSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=OWhat you can answer from here — as of September 23, 2026
8Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Cefpiramide, and which of those have an active Phase 3 trial?